Media Humiliated: Demo of Elon's Tech Proves They're Wrong

It's smaller than a quarter, but it could power Elon Musk's next AI revolution... A revolution he believes will be worth more than $9 trillion. Believe it or not, this device could even help put an extra $30k in your pocket every year outside of the markets.

PTC Therapeutics Inc
NASDAQ:PTCT
$45.84

Financials

Curr Year EPS Estimate-4.26
Next Quarter EPS Estimate-1.27
Profit Margin-50.32%
Operating Margin-14.18
Return on Assets-0.05
Return on Equity-77.40
Revenue900.7M
Earnings Per Share-5.94
Revenue Per Share11.79
Gross Profit2,627,000
Quarterly Revenue Growth0.00

General

NamePTC Therapeutics Inc
TickerPTCT
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees988

About PTC Therapeutics Inc

PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders in the United States and internationally. The company offers Translarna and Emflaza for the treatment of Duchenne muscular dystrophy; Upstaza to treat aromatic l-amino acid decarboxylas (AADC) deficiency, a central nervous system disorder; Tegsedi and Waylivra for the treatment of rare diseases; and Evrysdi to treat spinal muscular atrophy (SMA) in adults and children. Its development pipeline products include Sepiapterin for the treatment of phenylketonuria; PTC518 splicing platform, which is being developed for the treatment of Huntington's disease; and ferroptosis and inflammation platforms, including vatiquinone to treat Friedreich ataxia and utreloxastat for the treatment of amyotrophic lateral sclerosis. The company distributes its products through third-party distributors. It has collaborations with F. Hoffman-La Roche Ltd, Hoffman-La Roche Inc., the SMA Foundation, National Taiwan University, Akcea Therapeutics, Inc., and Shiratori Pharmaceutical Co., Ltd. The company has license and collaboration agreement with Novartis Pharmaceuticals Corporation to develop PTC518 Huntington's disease program. PTC Therapeutics, Inc. was incorporated in 1998 and is headquartered in South Plainfield, New Jersey.

Earnings

Popular

What's Going On With Rocket Lab Stock Thursday?

Rocket Lab stock may be moving higher amid continued strength after the company on Monday announced it completed its 16th successful mission of 2024.

What's Going On With Laser Photonics Shares Thursday?

Laser Photonics stock is trading higher after the company announced it received an order from Walsh Service Solutions.

There's Only ONE AI Company That Matters - Ad

It's not Nvidia, AMD, IBM, or any new startup. It's not even an artificial intelligence company... yet it holds the key to the entire AI market. Get all the details of the critical technology that the entire AI sector needs to survive.

What's Going On With Walmart Stock Monday? (UPDATED)

Walmart Inc. (NYSE:WMT) shares are trading lower on Monday. The Consumer Financial Protection Bureau (CFPB) filed a lawsuit against the company and Branch Messenger over concerns regarding junk fees. Here's what you need to know.

Payments of Up to $1,400 Coming for 1 Million Eligible Taxpayers, IRS Confirms

The IRS will issue automatic payments to approximately 1 million taxpayers who did not claim the 2021 Recovery Rebate Credit.

Scary Accurate AI Money Map Shows Strange Twist Coming for the Market - Ad

Over the last 5 years, this "scary accurate" AI Money Map has helped investors get in on the right stocks, at the right time -- during this AI revolution... Now it shows a strange twist is coming for the AI market that almost nobody sees coming... And worse still, no one's being warned about.

Warby Parker, RH, Bath & Body Works Are 'Stocks With Potential,' Analyst Says

Telsey Advisory Group analyst Dana Telsey on Tuesday provided an overview of which consumer sectors were the best performers in the third-quarter and highlighted some "stocks with potential."

Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More

JP Morgan highlights 2025 growth prospects for biopharma, animal health, and specialty pharma stocks. Key picks include Eli Lilly, Zoetis, and Bristol-Myers Squibb.

"This Will Be Worse Than the Great Depression, the Dot-Com Crash, and the 2008 Crisis Combined" - Ad

According to Dan Ferris, who has predicted nearly every major market crisis of the last 25 years, a new crisis in the US economy could soon cost you 50% of your portfolio or more if you don't prepare your wealth now. Especially if you're sitting on large gains.

Inside Jeff Bezos' $600M Wedding To Lauren Sánchez: Luxe Decor, Stars, And Romance

Jeff Bezos is reportedly set to marry his fiancée Lauren Sanchez next Saturday in a $600 million Winter Wonderland-themed wedding in Aspen, Colorado.

Why Is Jet.AI Stock Trading Over 100% On Tuesday?

Jet.AI Inc. (NASDAQ: JTAI) shares soar on launch of Ava, an AI model streamlining private jet bookings with personalized service and expert recommendations.

Is a Starlink IPO Coming in 2024? - Ad

Could there be signs that a Starlink IPO is set for the second half of 2024? According to one top venture capitalist, the answer is YES! And for the first time ever, you have the rare chance to profit pre-IPO... BEFORE Starlink goes public.

American Airlines settles lawsuit filed by 3 Black men who were ordered off a flight

American Airlines said Thursday it has settled a filed by three Black men who were ordered to deboard a flight last January.

Nissan, Honda expected to announce plans to merge, creating world's No. 3 automaker

TOKYO (AP) — Japanese automakers Nissan and Honda were expected to announce Monday that they are in talks on a merger that would catapult them to No. 3 in a global industry undergoing tectonic shifts as it transitions away from reliance on fossil fuels while facing intensifying competition from Chinese rivals.

My TOP Altcoin for Right Now Is... - Ad

Searching for the top investment opportunity in crypto? Look no further. Our $3 report gives you the full scoop. You'll get this exciting token's name, our recommended investment strategy, and growth projections. Time is of the essence with this one...

Southern Africa elections brought big changes in 2024

HARARE, Zimbabwe (AP) — In Southern Africa, where democracy remains relatively stable, elections held in 2024 saw long-governing liberation parties struggling to survive.

Trump Continues Court Battle With Media With Lawsuit Against Des Moines Register

President-elect Donald Trump has intensified his legal assault on the media, filing multiple lawsuits seeking damages for what he claims are false or misleading reports.

Did You See Trump's Bombshell Exec. Order 001? - Ad

Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001." It's a bombshell law that Trump could sign within minutes of stepping into the Oval Office... And it will instantly set off the most sweeping government technology project in 80 years... The most lucrative, too...

Starbucks strike expands, closes nearly 60 US stores

A by baristas had closed 59 stores as of Monday afternoon, according to the union organizing the workers.

Tesla Tackling 'Critical Safety Issue' In FSD With Audio Detection For Emergency Vehicles, Says Ross Gerber: 'Humans Use More Than One Sense To Drive'

Tesla Inc. needs to address a "critical safety issue" regarding its Full Self-Driving system's ability to detect emergency vehicles, according to prominent investor Ross Gerber, CEO of Gerber Kawasaki Wealth and Investment Management.

A Strange Twist Is About to Hit the AI Market That Almost Nobody Sees Coming... - Ad

If you have any money in AI stocks right now, or if you're even thinking about it, you need to see what's going on. The truth is, the moves we've seen in tech and AI stocks over the last couple of months could be the start of something much bigger. That's why I've put together this special presentation with Wall Street legend, Charles Mizrahi.

Elon Musk Changes Tone, Applauds Speaker Johnson: 'It Went From A Bill That Weighed Pounds To One That Weighed Ounces'

Elon Musk praised Speaker Mike Johnson's revised spending package to prevent a government shutdown, calling it a significant improvement, after initially expressing skepticism about the plan.

Could Trump's Favorite Coin Take Off Post-election? - Ad

Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150K -- or more. There's one coin he thinks could go up more . It's part of Trump's special Project Crypto. His plan to make America "the crypto capital of the planet."

Eli Lilly's Zepbound Receives FDA Approval For Obesity-Linked Sleep Apnea Drug

The FDA approved Eli Lilly's Zepbound as the first drug for obesity-linked moderate-to-severe sleep apnea, potentially transforming treatment options for 80 million Americans.

Johnson Averts Shutdown But Faces Growing Pressure From Right

House conservatives are pressuring Speaker Mike Johnson after a rocky week of negotiations and infighting over a government spending bill.

Bitcoin Skyrockets on Trump's Election. Which Coin Is Next? - Ad

Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150K -- or more. There's one coin he thinks could go up more . It's part of Trump's special Project Crypto. His plan to make America "the crypto capital of the planet."

Ex-OpenAI engineer who raised legal concerns about the technology he helped build has died

Suchir Balaji, a former OpenAI engineer and whistleblower who helped train the artificial intelligence systems behind ChatGPT and later said he believed those practices violated copyright law, has died, according to his parents and San Francisco officials. He was 26.

Man Who Called Nvidia Says "Buy These Five AI Stocks." - Ad

In 2016, Jeff Brown called Nvidia at a split-adjusted 66 cents. The company just became the world's third $3 trillion company...And the stock is up massively since Jeff's recommendation. Now, Jeff has found five under-the-radar stocks which could power your retirement. And it's in large part because these companies are connected to Elon Musk and Nvidia.

Cathie Wood's Thursday Moves: Dumps Buzzing Stocks Tesla And Palantir

On Thursday, Dec. 19, 2024 Cathie Wood-led Ark Invest sold shares of Tesla and Palantir, both of which have run up considerably for the month.

Here's What The Latest Congressional AI Report Could Mean For Big Tech

The House Artificial Intelligence Task Force released a report on Tuesday with recommendations on how Congress can boost the development of AI while also protecting against potential risks of the technology.

Is Artificial Intelligence the Biggest Bubble in History? - Ad

Is it any surprise 31 billionaires (including: Warren Buffett, Elon Musk, Jeff Bezos, and more) are quietly unloading their OWN stocks at record pace? They're getting OUT of AI (and Tech Stocks) before it's too late. But why? And WHERE are they moving their cash for the biggest profits, in 2024?

Elon Musk: "The Government Is Out of Control." - Ad

Elon Musk says the government is going bankrupt. Seniors are getting crushed by inflation. But there is a way you could claim a chunk of over $1 trillion in spending, courtesy of Elon Musk.

Elon Musk considers funding Nigel Farage's populist party, a move that could shake up UK politics

LONDON (AP) — It’s a photo that sent a tremor through British politics: flanked by British politician and a wealthy backer, in front of a gilt-framed painting of a young .

Sell Nothing. Retire Early. Mission Complete. - Ad

What if you could retire in 3 years instead of 10-15? While everyone is trying to trade the market and gamble on poop coins and meme coins, some people are using a little known method to actually earn passive returns. We probably have 3 years to exploit this before the party is over. That's plenty of time to retire early in crypto.

Russian central bank holds rates steady at 21% amid criticism from key business figures

Russia's central bank has left its benchmark interest rate at 21%, holding off on further increases as it struggles to snuff out inflation fueled by the government's spending on the war against Ukraine.

Recommended

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright finstrategist.com
Privacy Policy | Terms of Service